14th CPhI & P-MEC India Expo all set to be held in Noida from 24th to 26th November
Identifying opportunities and building partnerships with this year’s hybrid ‘CPhI P-MEC India Virtual Conference’ is the highlight of the India Pharma Week by Informa Markets
Informa Markets is all set to kick start the 14th edition of South Asia’s biggest Pharma event, CPhI & P-MEC India expo from 24th to 26th November, 2021 at the India Expo Centre, Greater Noida. The highlight of this year’s expo is the innovative Hybrid with a ‘CPhI P-MEC India Virtual Conference’ which is being held from 15th to 18th November, 2021, according to a statement from Informa Markets.
The statement also notified that over 534 exhibitors from 16 countries are expected.
With a focus on building new business partnerships and announcements, the three-day expo will deliver and discuss new trends in the industry to grow the economy. Keeping up with their annual promise, the event will host an exciting line-up of conferences expected to enlighten the guests by addressing the challenges and focusing on future opportunities of the pharmaceutical industry in India. This year too, the expo expects continued support from various pharmaceutical companies (generic finished products), API producers, distributors, pharmaceutical companies (innovator finished products), intermediates manufacturers, engineering and contract manufacturers, ingredients distributors/buyers, consultancies and packaging materials as well as associated support from Pharmexcil, CIPI, IDMA, ASPA, IPA, IPEC and KDPMA, it added.
The hybrid model ‘CPhI P-MEC India Virtual Conference’ will touch upon key topics like drug development and delivery, medical devices, SCM (logistics, exports and outsourcing), machinery and manufacturing, API and next-gen labs, regulatory updates, biosimilars, mAbs, pricing and market access, packaging and labelling, serialisation, track and trace, digitalisation – AI, IoT, blockchain and big data in pharma, said the statement.
The expo will host a series of sessions and workshops, presented and led by high-profile speakers and industry stalwarts, and ample support and representation from the government covering content from all aspects of the pharmaceutical industry. A keynote on ‘Recent initiatives by the authorities for the pharmaceutical and healthcare industry at the inauguration ceremony on day one will be followed by a first-panel discussion ‘Building Self Reliance at the core of the Pharmaceutical Industry with reduced import dependence for API’ that will focus on the COVID-19 pandemic that has disrupted the global supply chains and laid bare vulnerabilities across the world in critical industries such as pharmaceuticals and food.
The expo is a part of the offerings under the umbrella of the popular India Pharma Week (IPW) which ekes out solutions to challenges, and meets the business requirements of the pharma professionals. This year too, apart from the expo, the IPW will have powerful sessions under their banner. On day one, the offerings include The Pharma Connect Conference which brings all key stakeholders in the pharmaceutical industry on a single platform to discuss, deliberate and share their thoughts on achieving the next phase of growth in pharma. The CEO Roundtable which is a closed-door strategic gathering of CEOs of leading pharma and biopharma companies will comprise thought-provoking discussions on pharma developments in India, and will conclude with the India Pharma Awards, followed by the Women in Pharma Roundtable on day two which is an initiative aimed at acknowledging and celebrating the significant and continued contribution of women to the pharmaceutical industry in a closed-door roundtable discussion.
Commenting on this year’s CPhI & P-MEC India Expo, Yogesh Mudras, Managing Director, Informa Markets in India, said, “The CPhI & P-MEC India Expo is an inherent part of our magnum opus, India Pharma Week (IPW), an array of marquee events celebrating the pharma industry. Always staying sensitive and true to trends, this year, the theme for the IPW is really to Reconnect and Rebuild, to achieve the next phase of growth for the Indian pharma domain. With a 15 per cent growth rate annually, the India Pharmaceutical market is a well-established sector with strong local manufacturing capabilities and an international export profile, and therefore, it is important to capture new market trends, innovate, adapt and seek newer opportunities to reach goals. We are thrilled to set ourselves back on track with this year’s expo, and while we are still fighting the global pandemic, we are delighted to see such a positive response from our international delegates. We look forward to a great response, and we promise all our guests a safe and productive experience at the India Pharma Week.”